查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046214

周邊血管器材市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區、競爭格局分類，2021-2031年

Peripheral Vascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球周邊血管器械市場預計將從 2025 年的 107.1 億美元成長到 2031 年的 160.9 億美元，複合年成長率為 7.02%。

該市場涵蓋介入性醫療設備，例如支架、導管、血管成形術用氣球和動脈粥狀硬化斑塊切除術系統，這些器械專門用於治療心臟和腦血管以外的其他血管疾病。推動市場成長的主要因素是周邊動脈疾病(PAD) 在全球範圍內的盛行率不斷上升，這與人口老化以及糖尿病和肥胖等文明病的日益普遍密切相關。此外，臨床上對重組手術的偏好從傳統開放性手術到微創血管內治療的顯著轉變也是重要的驅動力，因為這些現代技術能夠縮短患者的恢復時間並降低併發症發生率。然而，該市場面臨的主要挑戰在於漏診率高以及民眾對該疾病的認知度低。檢測延遲往往會導致疾病進展到器械治療無效的階段，從而限制了目標市場規模。根據血管外科協會預測，到 2025 年，超過 68% 的美國人將不了解周邊動脈疾病。病患教育的這一重大差距嚴重阻礙了早期篩檢工作，並限制了周邊血管治療在全球的普及。

市場概覽
預測期 2027-2031
市場規模：2025年 107.1億美元
市場規模：2031年 160.9億美元
複合年成長率：2026-2031年 7.02%
成長最快的細分市場 醫院
最大的市場 北美洲

市場促進因素

糖尿病及相關文明病的激增是全球周邊血管器械市場的主要驅動力。慢性高血糖和肥胖會加速動脈粥狀硬化的進展，直接增加患者患有周邊動脈疾病（PAD）和嚴重下肢缺血的風險，從而導致對介入治療以預防截肢的需求持續成長。根據國際糖尿病聯盟（IDF）發布的《IDF糖尿病地圖集》（第11版），到2025年，全球約11.1%的成年人口將患有糖尿病，凸顯了需要持續血管管理的患者群體規模龐大且不斷成長。同時，微創血管內治療的模式轉移以及持續的技術創新正在顯著推動市場發展。由於導管介入手術能帶來更好的病患預後，包括縮短住院時間和降低手術相關風險，臨床醫師越來越傾向於選擇導管介入手術而非傳統開放性手術。藥物釋放型球囊和新一代支架平台等醫療設備的改進進一步推動了這一轉變，並促使手術數量不斷增加。例如，雅培醫療設備部門公佈的2024年第四季及全年業績（截至2025年1月）顯示，其有機銷售額成長14.0%，反映出其介入治療技術的廣泛應用。同樣，Medtronic2025會計年度業績（截至2025年5月）顯示，其心血管產品組合的年銷售額達到124.81億美元，證實了全球對血管治療解決方案的強勁需求。

市場挑戰

嚴重的誤診和疾病認知度低從根本上限制了全球周邊血管器械市場的收入潛力，因為這限制了可治療患者的數量。器械製造商依賴早期識別適合接受微創介入治療（例如血管成形術和支架置入術）的患者。然而，腿痛等症狀常被患者視為正常的老齡化徵兆而忽視，導致大量患者直到病情嚴重才就醫。這種延誤導致目標市場大幅萎縮，因為漏診直接減少了利用先進血管技術進行治療的機會。缺乏對高風險族群的主動臨床干預進一步加劇了這項挑戰。根據心血管血管造影術和介入學會 (SCAI) 預測，到 2025 年，80% 的黑人和西班牙裔成年人將從未從醫療專業人員那裡了解周邊動脈疾病。患者與醫療專業人員之間如此巨大的溝通鴻溝意味著大規模人群的疾病仍未得到診斷和治療，這給醫療設備的使用帶來了重大障礙。因此，市場成長放緩，實際臨床需求遠低於基於盛行率的潛在需求。

市場趨勢

周邊血管市場最顯著的結構性變化之一是手術轉移到門診手術中心 (ASC) 和診所內檢查室(OBL)。這一趨勢的促進因素是有利的報銷模式和營運效率的提高。這種轉變使得在血管成形術等介入治療中，能夠在確保臨床安全性的同時降低間接成本。因此，製造商需要調整其商業策略，不僅要滿足大規模醫院網路的需求，還要滿足獨立醫療機構的需求。美國心臟學會 (ACC) 於 2025 年 11 月發布的分析報告《周邊血管介入治療的治療方法與趨勢》顯示，基於報銷數據的回顧，在 ASC/OBL 環境中進行的血管重建手術比例正在迅速成長，佔所有手術的 47%。同時，血管內碎石術 (IVL) 的日益普及正在重新定義嚴重鈣化病變的治療方法，這些病變通常會使血管內治療的效果複雜化。與傳統球囊不同，血管內震波碎石術（IVL）利用聲波壓力擊碎血管壁內的鈣化，從而在支架置入前最佳化血管順應性，並實現複雜病例的成功血管重建。這項技術已成為治療晚期周邊動脈疾病的關鍵手段，並直接推動了主要產業參與者的收入成長。例如，強生公司心血管部門在其2025年第三季財報（2025年10月發布）中披露，銷售額成長了12.6%，這一成長主要歸功於其Shockwave血管內衝擊波碎石平台在全球範圍內需求的加速成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球周邊血管器械市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（周邊血管支架、PTA球囊、導管、用於血管內動脈瘤修復的支架血管支架、斑塊修飾裝置、周邊血管附件、下腔靜脈濾器、血流動力學調節裝置）
    • 依最終使用者（醫院、診所、門診手術中心）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美周邊血管器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲周邊血管器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區周邊血管器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲周邊血管器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲周邊血管器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球周邊血管器械市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • AngioScore Inc.
  • Edward Lifesciences Corporation
  • Medtronic Plc.
  • Teleflex Inc.
  • Volcano Corporation
  • Boston Scientific Corporation
  • Cook Group Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15454

The Global Peripheral Vascular Devices Market is projected to expand from USD 10.71 billion in 2025 to USD 16.09 billion by 2031, exhibiting a 7.02% Compound Annual Growth Rate (CAGR). This market comprises interventional medical instruments, such as stents, catheters, angioplasty balloons, and atherectomy systems, specifically designed for treating vascular diseases that affect blood vessels outside the heart and brain. Growth is primarily underpinned by the increasing global prevalence of peripheral artery disease (PAD), which is closely linked to an aging population and the rising incidence of lifestyle-related conditions like diabetes and obesity. Moreover, a significant shift in clinical preference from traditional open surgical revascularization to minimally invasive endovascular procedures acts as a powerful driver, as these modern methods offer patients reduced recovery times and lower complication rates. However, a major market challenge stems from the high rate of underdiagnosis and limited disease awareness among the general public. Delayed detection often leads to disease progression beyond the point where device-based intervention is effective, consequently limiting the addressable market size, with over 68% of Americans reportedly unaware of peripheral artery disease in 2025, according to the Society for Vascular Surgery. This critical gap in patient education significantly hinders early screening efforts and restricts the global utilization of peripheral vascular interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 10.71 Billion
Market Size 2031USD 16.09 Billion
CAGR 2026-20317.02%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Market Driver

The escalating incidence of diabetes and related lifestyle comorbidities stands as a primary catalyst for the Global Peripheral Vascular Devices Market. Chronic hyperglycemia and obesity accelerate atherosclerosis progression, directly increasing patient susceptibility to peripheral artery disease (PAD) and critical limb ischemia, thereby creating a sustained demand for interventional therapies to prevent amputations. In 2025, approximately 11.1% of the global adult population was living with diabetes, as reported by the International Diabetes Federation's 'IDF Diabetes Atlas 11th Edition,' highlighting a vast and expanding patient pool requiring ongoing vascular management. Concurrently, a paradigm shift towards minimally invasive endovascular interventions, coupled with continuous technological innovation, is significantly propelling the market. Clinicians increasingly favor catheter-based techniques over traditional open surgery due to superior patient outcomes, including shorter hospital stays and reduced procedural risks. This transition is further supported by advancements in device capabilities, such as drug-coated balloons and next-generation stent platforms, which drive higher procedural volumes. For instance, Abbott's Medical Devices segment reported a 14.0% organic sales increase in its 'Fourth-Quarter and Full-Year 2024 Results' (January 2025), reflecting strong adoption of its interventional technologies. Similarly, Medtronic's Cardiovascular Portfolio generated $12.481 billion in annual revenue in 'Fiscal Year 2025 Financial Results' (May 2025), underscoring robust global expenditure on vascular care solutions.

Market Challenge

The substantial rates of underdiagnosis and low disease awareness fundamentally constrain the revenue potential of the global peripheral vascular devices market by limiting the volume of treatable patients. Device manufacturers depend on the early identification of candidates for minimally invasive interventions such as angioplasty or stenting. However, symptoms like leg pain are often dismissed by patients as normal signs of aging, preventing a significant portion of the affected population from seeking medical advice until their condition becomes severe. This delay results in a considerable contraction of the addressable market, as missed diagnoses directly translate into fewer procedural opportunities for utilizing advanced vascular technologies. This challenge is further exacerbated by a lack of proactive clinical engagement with high-risk populations. In 2025, 80% of Black and Hispanic adults reported that a healthcare provider had never discussed peripheral artery disease with them, according to the Society for Cardiovascular Angiography and Interventions. Such critical gaps in patient-provider communication create a significant barrier to device usage, as the condition remains unidentified and untreated within a large demographic. Consequently, the market experiences suppressed growth rates, with the actual clinical demand falling considerably short of its prevalence-based potential.

Market Trends

A prominent structural transformation in the peripheral vascular market involves the migration of procedures to Ambulatory Surgical Centers (ASCs) and Office-Based Labs (OBLs), a trend driven by favorable reimbursement models and enhanced operational efficiency. This shift enables reduced overhead costs while maintaining clinical safety for interventions like angioplasty, necessitating that manufacturers adapt their commercial strategies to cater to independent facilities rather than solely large hospital networks. According to an American College of Cardiology analysis in November 2025, which examined fee-for-service claims in 'Studies Examine Current Treatments and Trends For Peripheral Vascular Interventions,' the proportion of total revascularizations performed in ASC and OBL environments has surged to 47% of the total procedural volume. Simultaneously, the widespread adoption of Intravascular Lithotripsy (IVL) is redefining the treatment of heavily calcified lesions that often complicate endovascular outcomes. Unlike traditional balloons, IVL utilizes sonic pressure waves to fracture calcium deposits within the vessel wall, thereby optimizing vessel compliance prior to stent deployment and enabling successful revascularization in complex cases. This technology has become essential for treating advanced peripheral artery disease, directly fueling revenue expansion for major industry players. For instance, Johnson & Johnson's Cardiovascular segment delivered a reported sales increase of 12.6% in its 'Q3 2025 Results' (October 2025), a growth trajectory primarily attributed to the accelerating global demand for its Shockwave intravascular lithotripsy platform.

Key Market Players

  • Abbott Laboratories
  • AngioScore Inc.
  • Edward Lifesciences Corporation
  • Medtronic Plc.
  • Teleflex Inc.
  • Volcano Corporation
  • Boston Scientific Corporation
  • Cook Group Inc.

Report Scope

In this report, the Global Peripheral Vascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peripheral Vascular Devices Market, By Type

  • Peripheral Stents
  • PTA Balloons
  • Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Plaque Modification Devices
  • Peripheral Accessories
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices

Peripheral Vascular Devices Market, By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Peripheral Vascular Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peripheral Vascular Devices Market.

Available Customizations:

Global Peripheral Vascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peripheral Vascular Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices)
    • 5.2.2. By End User (Hospitals, Clinics, Ambulatory Surgical Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Peripheral Vascular Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peripheral Vascular Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Peripheral Vascular Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Peripheral Vascular Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Peripheral Vascular Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Peripheral Vascular Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Peripheral Vascular Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Peripheral Vascular Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Peripheral Vascular Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Peripheral Vascular Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Peripheral Vascular Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Peripheral Vascular Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Peripheral Vascular Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Peripheral Vascular Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Peripheral Vascular Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Peripheral Vascular Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Peripheral Vascular Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Peripheral Vascular Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Peripheral Vascular Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Peripheral Vascular Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. South America Peripheral Vascular Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Peripheral Vascular Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Peripheral Vascular Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Peripheral Vascular Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Peripheral Vascular Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. AngioScore Inc.
  • 15.3. Edward Lifesciences Corporation
  • 15.4. Medtronic Plc.
  • 15.5. Teleflex Inc.
  • 15.6. Volcano Corporation
  • 15.7. Boston Scientific Corporation
  • 15.8. Cook Group Inc.

16. Strategic Recommendations

17. About Us & Disclaimer